Book of Medical Disorders in Pregnancy - Tintash
Book of Medical Disorders in Pregnancy - Tintash
Book of Medical Disorders in Pregnancy - Tintash
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Poliomyelitis has also been reponed to<br />
produce paralysis more frequently<br />
dur<strong>in</strong>g pregnancy. Vacc<strong>in</strong>ation aga<strong>in</strong>st<br />
smallpox and polio is therefore<br />
mandatory, when the risk <strong>of</strong> exposure is<br />
high, while tetanus toxoid can be given<br />
to pregnant women, <strong>in</strong> whom immunity<br />
has been found to have lapsed.<br />
Cholera, typhoid, and <strong>in</strong>fluenza vacc<strong>in</strong>es<br />
are known to <strong>of</strong>fer poor or transient<br />
immunity. Globul<strong>in</strong>s provide protection<br />
for only a def<strong>in</strong>ed period <strong>of</strong> time and are<br />
used primarily for the prophylaxis <strong>of</strong><br />
measles and hepatitis.<br />
Rubella vacc<strong>in</strong>e viruses, poten-tially<br />
share the same teratogenic pro-perties as<br />
the wild rubella virus, but they have not<br />
been shown to produce birth defects.<br />
However, pregnancy is a contra<strong>in</strong>dication<br />
to rubella as well as to<br />
measles and mumps vacc<strong>in</strong>ation,<br />
because a viral <strong>in</strong>fection <strong>of</strong> the foetus<br />
can occur and may damage the foetus.<br />
Exaggerated.<br />
Febrile responses to any vacc<strong>in</strong>ation<br />
may also jeopardize the pregnancy.<br />
Gamma globul<strong>in</strong> usually protects the<br />
susceptible <strong>in</strong>dividual from measles if<br />
given with<strong>in</strong> 48 hours <strong>of</strong> exposure. S<strong>in</strong>ce<br />
measles have been reported to cause<br />
abortion <strong>in</strong> up to 50% <strong>of</strong> <strong>in</strong>fected<br />
pregnant women. The use <strong>of</strong> gamma<br />
globul<strong>in</strong> is justified on this account.<br />
Immunization aga<strong>in</strong>st tetanus: Active<br />
immunization aga<strong>in</strong>st tetanus can be<br />
carried out dur<strong>in</strong>g pregnancy without<br />
<strong>in</strong>jury to the foetus. The <strong>in</strong>fant can be<br />
protected aga<strong>in</strong>st neonatal tetanus by<br />
vacc<strong>in</strong>at<strong>in</strong>g the mother. This is a matter<br />
<strong>of</strong> great importance <strong>in</strong> rural areas, where<br />
the <strong>in</strong>cidence <strong>of</strong> neonatal tetanus may be<br />
high as a result <strong>of</strong> <strong>in</strong>fection <strong>of</strong> the<br />
174<br />
umbilical stump. A subcutaneous <strong>in</strong>jection<br />
<strong>of</strong> tetanus toxoid adsorbed on to<br />
alum<strong>in</strong>ium hydroxide should be given as<br />
early <strong>in</strong> pregnancy as possible. The<br />
second dose should follow six weeks<br />
later and the f<strong>in</strong>al dose six months after<br />
that, or earlier if labour is due before that<br />
time. When a woman has already been<br />
immunized <strong>in</strong> the past a booster dose <strong>of</strong><br />
toxoid may be given <strong>in</strong> the last trimester.<br />
REFERENCES:<br />
1. Grossman, J.H. Per<strong>in</strong>atal Viral<br />
<strong>in</strong>fections. Cl<strong>in</strong>. Per<strong>in</strong>atol. 7:257, 1980.<br />
2. Rossi, M. et al. Maternal rubella and<br />
hear<strong>in</strong>g impairment children. J.<br />
Laryngol. Otol. 94:281, 1980<br />
3. Polk, B. F., et al. An outbreak <strong>of</strong> rubella<br />
among hospital personnel N. Engl. J.<br />
Med. 303:541, 1980.<br />
4. Krugman, S. Rubella Immunization.<br />
Present status and future perspectives.<br />
Pediatrics. 65:1174, 1980.<br />
5. Griffiths, P.O., et al. A prospective<br />
study <strong>of</strong> primary cytomegalovirus<br />
<strong>in</strong>fection <strong>in</strong> pregnant women. Br. J.<br />
Obstet. Gynaecol. 87:308,1980.<br />
6. Griffiths, P.O. et al. Persistence <strong>of</strong> high<br />
titer antibodies to the early antigens <strong>of</strong><br />
cytomegalvirus <strong>in</strong> pregnant women.<br />
Arch. Virol. 64:303,1980.<br />
7. Gladstone, J.L., and Millan, S.J.<br />
Rubella exposure <strong>in</strong> an obstetric cl<strong>in</strong>ic.<br />
Obstet. Gynecol. 57:182,1981.